Bixiye
QP45-24 Commercial Pharmacy Benefit Exclusion for Jesduvroq, Tofidence™, and Tyenne®
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2024
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 561 - 570 ee natiijooyinka 3607
Bixiye
QP47-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 15, 2024
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2024
Bixiye
P41-24 Change to Management of Medical Specialty Drugs
Taariikhda wax ku ool ah ee barnaamijka: Jun 03, 2024
Bixiye
P39-24 New and Updated Reimbursement Policies, Effective August 5, 2024
Taariikhda wax ku ool ah ee barnaamijka: Jun 03, 2024
Bixiye
2024 June Bulletins
Taariikhda wax ku ool ah ee barnaamijka: Jun 03, 2024
Bixiye
P40-24 MCG Care Guidelines 28th Edition
Taariikhda wax ku ool ah ee barnaamijka: Jun 03, 2024
Bixiye
P38-24 eviCore Healthcare Specialty Utilization Management (UM) Program: Cardiology and Radiology Clinical Guideline Updates
Taariikhda wax ku ool ah ee barnaamijka: Jun 03, 2024
Bixiye
P42-24 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Taariikhda wax ku ool ah ee barnaamijka: Jun 03, 2024
Bixiye
P37-24 Residential Treatment Claims for Minnesota Health Care Programs
Taariikhda wax ku ool ah ee barnaamijka: Jun 03, 2024
Bixiye
Atypical Antipsychotics - Medicaid
Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025